To access the Medicare Part D formulary status of ZETIA using this tool, simply select your state from the first drop-down menu, then specify your managed care market by selecting from the second drop-down menu.

Formulary status is believed to be accurate but cannot be guaranteed. Formulary status for national plans may not reflect plan variation at the local level.

Updated formulary status information for Medicare plans may be available from the Centers for Medicare & Medicaid Services: www.medicare.gov.

	The effect of ZETIA on cardiovascular morbidity and mortality has not been determined.
	ZETIA, administered alone or in combination with an HMG-CoA reductase inhibitor (statin), is indicated as adjunctive therapy to diet for the reduction of elevated TOTAL-C, LDL-C, and Apo B in patients with primary (heterozygous familial and nonfamilial) hyperlipidemia when diet alone is not enough.
SELECTED CAUTIONARY INFORMATION
	ZETIA is not recommended in patients with moderate to severe hepatic impairment.
	The coadministration of ZETIA with fibrates other than fenofibrate is not recommended until use in patients is adequately studied.
	Exercise caution when using ZETIA and cyclosporine concomitantly because exposure to both drugs is increased. Cyclosporine concentrations should be monitored in these patients.
	ZETIA should be used in pregnant or nursing women only if the benefit outweighs the risk.
	In clinical trials, regardless of causality assessment, the most frequent side effects for ZETIA coadministered with a statin vs statin alone included nasopharyngitis (3.7% vs 3.3%), myalgia (3.2% vs 2.7%), upper respiratory tract infection (2.9% vs 2.8%), arthralgia (2.6% vs 2.4%), and diarrhea (2.5% vs 2.2%); for ZETIA administered alone vs placebo: upper respiratory tract infection (4.3% vs 2.5%), diarrhea (4.1% vs 3.7%), arthralgia (3.0% vs 2.2%), sinusitis (2.8% vs 2.2%), pain in extremity (2.7% vs 2.5%), and fatigue (2.4% vs 1.5%).

Before prescribing ZETIA, please read the Prescribing Information.

For non-US health care professionals, click here.